Clinical experience reversing factor Xa inhibitors with four-factor prothrombin complex concentrate in a community hospital

Gelijkaardige items

• Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
  door: Rech, Megan A., et al.
  Gepubliceerd in: (2021)
• Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro
  door: Herm Jan M. Brinkman, et al.
  Gepubliceerd in: (2022-03-01)
• Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
  door: Tao, Jing, et al.
  Gepubliceerd in: (2018)
• Andexanet versus prothrombin complex concentrates: Differences in reversal of factor Xa inhibitors in in vitro thrombin generation
  door: Lu, Genmin, et al.
  Gepubliceerd in: (2020)
• Use and outcomes of prothrombin complex concentrate for factor Xa inhibitor-associated bleeding
  door: Frank, Annabel K., et al.
  Gepubliceerd in: (2020)